| abstract |
Imidazopyrazinone derivative compounds having the structure of Formula 1, pharmaceutically acceptable salts, isomers, hydrates, or solvates thereof and pharmaceutical compositions comprising the same as active ingredients are produced by overexpression of apoptosis inhibiting protein. It is effective in preventing and treating cancer, inflammation, autoimmune diseases and neurodegenerative disorders. [Formula 1] In Formula 1, X, and R 1 to R 8 are as defined in the specification text. |